0.09 USD
-0.03 (-26.83%)
0.06 USD
-0.03 (-33.33%)
ChartMill assigns a Buy % Consensus number of 43% to AFIB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.53. This target is 1600% above the current price.
- AFIB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AFIB.
- In the previous month the buy percentage consensus was at a similar level.
- AFIB was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-16 | Goldman Sachs | Maintains | Neutral |
| 2022-06-24 | BTIG | Maintains | Buy |
| 2022-04-27 | BTIG | Upgrade | Neutral -> Buy |
| 2022-04-14 | Goldman Sachs | Maintains | Neutral |
| 2022-01-20 | BTIG | Downgrade | Buy -> Neutral |
| 2022-01-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2021-11-12 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-11-12 | Canaccord Genuity | Maintains | Buy |
| 2021-10-22 | Goldman Sachs | Initiate | Neutral |
| 2021-07-15 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2021-03-19 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-03-19 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-03-19 | Canaccord Genuity | Maintains | Hold |
ACUTUS MEDICAL INC / AFIB FAQ
What is the price target for AFIB stock?
6 analysts have analysed AFIB and the average price target is 1.53 USD. This implies a price increase of 1600% is expected in the next year compared to the current price of 0.09.
Can you provide the consensus rating for ACUTUS MEDICAL INC stock?
The consensus rating for ACUTUS MEDICAL INC (AFIB) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.